UXN
UXN engages in the manufacture and sale of medical devices such as continuous glucose monitoring instrument and blood glucose sensor.
UXN
Industry:
Health Care Health Diagnostics Manufacturing Medical Medical Device
Founded:
2012-05-15
Address:
Yeongyang, Kyonggi-do, South Korea
Country:
South Korea
Website Url:
http://www.uxn.co.kr
Total Employee:
11+
Status:
Active
Contact:
+8228580931
Email Addresses:
[email protected]
Total Funding:
1000 M KRW
Technology used in webpage:
Nginx Google Apps For Business PHP PHP 7 Sectigo SSL Sectigo Domain SSL Korea Telecom
Similar Organizations
EasyNotes Medical
EasyNotes Medical engages in the development, manufacture, and marketing of medical devices for the endoscopic treatment of Type 2 diabetes.
Japan Medicalnext
Japan Medicalnext provides the manufacture and sale of medical devices like diagnostic systems, surgery tools, infusers, and support robots.
Japan Vietnam Medical Instrument
Japan Vietnam Medical Instrument makes medical equipment such as diagnostic imaging products like computer tomography, MRI & x-ray systems.
Medico Electrodes
Medico Electrodes is a manufacturer and supplier of disposable ECG electrodes for cardiac monitoring and diagnostic procedures.
Terumo Cardiovascular Systems
Terumo Medical Corporation is the manufacturer of medical devices and supplies for health care support.
UMedic Healthcare
UMediC Healthcare manufactures and supplies patient monitoring systems, hospital furniture, anesthesia, and ultrasound equipment.
Vigilenz
Vigilenz is a manufacturer and supplier of medical devices and consumables, primarily active in wound management and infection control.
WAP
WAP specializes in the production of medical devices such as AED defibrillators, AED cabinets, and AED accessories.
Investors List
Hyundai Investment Partners
Hyundai Investment Partners investment in Seed Round - UXN
Official Site Inspections
http://www.uxn.co.kr
- Host name: 183.111.174.78
- IP address: 183.111.174.78
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "UXN"
UXN - 유엑스엔
Agms 연속혈당측정 시스템 Technology 03. 연속혈당측정은 전기화학기술과 바이오센서 기술을 바탕으로 사용자의 혈당변화를 채혈없이 간편하게 실시간 모니터링하는 진단기술입니다.See details»
Welcome to UXN - uxn.co.kr
Sunkil Kang, Ph.D., joined UXN in April 2021 as Vice President and became Chief Technology Officer in June, bringing more than 20 years of bio sensors and bio chips development …See details»
유엑스엔 - uxn.co.kr
설립일. 2012년 05월 15일 (상장일 2019년 11월 28일)See details»
UXN - Crunchbase Company Profile & Funding
UXN closed its last funding round on Aug 13, 2020 from a Seed round. Who are UXN 's competitors? Alternatives and possible competitors to UXN may include Human Zhizao , …See details»
UXN Co., Ltd. (XKON: 337840) Company Profile & Overview
Nov 4, 2024 UXN Co., Ltd. develops and produces Gluco-Chaser, a continuous glucose monitoring system for managing type-I and type-II diabetes; and Always continuous glucose …See details»
UXN Co Company Profile 2024: Stock Performance & Earnings
Uxn.co.kr. Ownership Status. Publicly Held. Financing Status. Corporation. Corporate Office. 8 Cheomdanventure-ro 28beon-gil; Buk-gu; Gwangju, 61009; South Korea; Primary Industry. …See details»
유엑스엔 | IR PAGE
유엑스엔] 패러다임을 바꿀 새로운 cgm_키움증권 기업분석(2022년 10월 27일) ir자료 2022.10.27 [유엑스엔] 무효소식 cgm 2023년 인허가 목표_db금융투자 기업분석(2022년 6월 14일) ir자료 …See details»
UXN CO.,LTD. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for UXN CO.,LTD. of Uiwang, Gyeonggi. Get the latest business insights from Dun & Bradstreet.See details»
Company UXN Co., Ltd. - MarketScreener.com
UXN Co., Ltd.: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Korea S.E.: A337840 | Korea S.E.See details»
About Uxn Co Ltd (337840) - Investing.com
Get an in-depth profile of Uxn Co Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information. ... Web …See details»
UXN - Products, Competitors, Financials, Employees, Headquarters …
Uxn.co.kr. Overview & Products; Financials; Founded Year 2012. Stage IPO | IPO. Total Raised $5.1M. Date of IPO ... UXN's technology is primarily aimed at the healthcare industry, with a …See details»
UXN Co. Ltd. Company & People | 337840 - Barron's
UXN Co. Ltd. company and executive profile by Barron's. View the latest 337840 company infomation and executive bios.See details»
유엑스엔 - uxn.co.kr
Our address 주소 경기도 의왕시 오봉산단3로 25, 1동 5층 505호 의왕테크노파크 더리브비즈원(삼동)See details»
UXN Co., Ltd. Stock (A337840) - Quote Korea S.E.- MarketScreener
3 days ago UXN Co., Ltd. is a Korea-based company principally engaged in the development of blood glucose monitoring devices. Based on the enzyme free electrochemical glucose sensor …See details»
337840 | UXN Co. Ltd. Profile - MarketWatch
UXN Co. Ltd. company facts, information and financial ratios from MarketWatch.See details»
UXN Co. Ltd. Stock Quote (Korea KONEX) - MarketWatch
337840 KR. Open. Last Updated: Nov 8, 2024 12:00 a.m. CEST ... UXN Co. Ltd. UXN Co., Ltd. engages in the manufacture and sale of bio-sensors. Its products include Gluco-chaser, which …See details»
337840 | UXN Co. Ltd. Stock Overview (Korea KONEX) | Barron's
Complete UXN Co. Ltd. stock information by Barron's. View real-time 337840 stock price and news, along with industry-best analysis.See details»
UXN Co., Ltd. (A337840) Company Information - Simply Wall St
Learn more about UXN Co., Ltd. (A337840). From their employee growth over the years and their exchange listings. Dashboard Portfolios Watchlist Community Discover Screener. ...See details»
UXN (XKON:A337840) - Stock Price, News & Analysis - Simply Wall …
Nov 23, 2024 UXN Co., Ltd. announced that it has received KRW 5.00024544 billion in funding from EOFLOW Co.,Ltd. and other investors Aug 10. UXN Co., Ltd., Annual General Meeting, …See details»
UXN (XKON:A337840) - Earnings & Revenue Performance - Simply …
Discover the latest data for UXN financials. From earnings and revenue to ROE, net margins, growth rates and more. Subscribe for free today!See details»